Skip to content
DataLookout
Menu

PRECISE-AFMR INCT07741253

PRECISE-AFMR I: Transcatheter Mitral Valve Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation in Patients at High Surgical Risk

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Recruitment opened Show 4 more changesShow less
    • Start date: Aug 2026 to Oct 25, 2026
    • Eligibility criteria revised
    • Secondary endpoints: details revised at 3 of 18 entries
    • Site details revised
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Composite endpoint of all-cause mortality or hospitalization for heart failure within 12 months after randomization.
Timeframe: Within 12 months after randomization.
Composite endpoint of device-related major adverse events.
Timeframe: Within 12 months after randomization.

Secondary (18)

Hierarchical composite endpoint of all-cause mortality, hospitalization for heart failure, or urgent emergency department/outpatient intensification of heart failure therapy within 12 months after randomization
Proportion of patients with MR ≤1+ at 30 days, 6 months, and 12 months
Proportion of patients with MR ≤2+
Residual MR grade and change from baseline
Change in NYHA functional class and proportion of patients in NYHA class I/II
Show 13 moreShow less
Change from baseline in left atrial anteroposterior diameter
Change from baseline in left atrial volume index (LAVI)
Change from baseline in 6-minute walk distance (6MWD)
Change from baseline in Kansas City Cardiomyopathy Questionnaire (KCCQ) score
Change from baseline in BNP or NT-proBNP level
Number of recurrent hospitalizations for heart failure
All-cause mortality
Cardiovascular mortality
Non-cardiovascular mortality
First hospitalization for heart failure
Total number of hospitalizations for heart failure
Emergency department visits or outpatient events requiring intensification of heart failure therapy
Composite endpoint of major procedure-related adverse events

Arms and interventions

TEER plus optimized GDMT groupExperimental
Optimized GDMT groupNo intervention

Devices: Transcatheter Edge-to-Edge Repair

Sites

1 site in 1 country

  • Fuwai HospitalBeijing, China